IMAGIN MEDICAL INC. Net Assets

Latest as of : €- EUR ≈ $- USD

IMAGIN MEDICAL INC. net assets. Based on the latest financial reports, IMAGIN MEDICAL INC. (DPD3) has net assets worth €- EUR (≈ $- USD) as of . Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€- ≈ $- USD) and total liabilities (€- ≈ $- USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how fast is IMAGIN MEDICAL INC. growing its equity to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric Value
Current Net Assets €-
% of Total Assets 0%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility N/A

Net Assets of IMAGIN MEDICAL INC. (2021–2022)

Net assets of IMAGIN MEDICAL INC. from 2021 to 2022. This chart illustrates how IMAGIN MEDICAL INC.'s net assets have evolved over time, based on quarterly financial data. See IMAGIN MEDICAL INC. (DPD3) net asset quality to measure how much of total assets are equity-financed.

Annual Net Assets for IMAGIN MEDICAL INC. (2021–2022)

The table below shows the annual net assets of IMAGIN MEDICAL INC. from 2021 to 2022. For live market cap and overall valuation, see IMAGIN MEDICAL INC. (DPD3) market capitalisation.

Year Net Assets Change
2022-09-30 €-13.34 Million
≈ $-15.59 Million
-15.55%
2021-09-30 €-11.54 Million
≈ $-13.49 Million
--

Equity Component Analysis

This analysis shows how different components contribute to IMAGIN MEDICAL INC.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 249220700.0% over the analyzed period, potentially due to dividend distributions or operating losses.

IMAGIN MEDICAL INC. Net Assets Breakdown (September 2022)

IMAGIN MEDICAL INC. net assets breakdown by equity component as of September 2022.

Component Amount Percentage
Other Components €21.28 Million %
Total Equity €-13.34 Million 100.00%

IMAGIN MEDICAL INC. Competitors by Market Cap

The table below lists competitors of IMAGIN MEDICAL INC. ranked by their market capitalization.

Company Market Cap
Mobile Global Esports Inc.
NASDAQ:MGAM
$6.45K
Captivision Inc
NASDAQ:CAPT
$6.53K
Windtree Therapeutics Inc
NASDAQ:WINT
$6.74K
Bimi International Medical Inc
NASDAQ:BIMI
$6.98K
Secure Property Development & Investment Plc
LSE:SPDI
$6.29K
Enteq Upstream
LSE:NTQ
$6.19K
CuChi Commercial and Industrial Developing Investment JSC
VN:CCI
$6.10K
daVictus plc
LSE:DVT
$6.09K

Equity Growth Attribution

This analysis shows how different factors contributed to changes in IMAGIN MEDICAL INC.'s equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2021 to 2022, total equity changed from -11,540,679 to -13,335,062, a change of -1,794,383.
  • Net loss of 2,492,207 reduced equity.
  • New share issuances of 13,707 increased equity.
  • Other factors increased equity by 684,117.

Equity Change Factors (2021 to 2022)

Factor Impact Contribution
Net Income €-2.49 Million -18.69%
Share Issuances €13.71K +0.1%
Other Changes €684.12K +5.13%
Total Change €- %

Book Value vs Market Value Analysis

This analysis compares IMAGIN MEDICAL INC.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2021-09-30 €-1.25 €0.00 x
2022-09-30 €-1.23 €0.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently IMAGIN MEDICAL INC. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2021 0.00% 0.00% 0.00x 0.00x €-10.32 Million
2022 0.00% 0.00% 0.00x 0.00x €-1.16 Million

Industry Comparison

This section compares IMAGIN MEDICAL INC.'s net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $41,410,799,518
  • Average return on equity (ROE) among peers: -32.95%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
IMAGIN MEDICAL INC. (DPD3) €- 0.00% N/A $6.33K
LEPU MED.T.B. SP.GDR O.N. (07Z0) $17.76 Billion 5.42% 0.47x $168.20K
BIORETEC OY (0TN) $9.76 Million -97.14% 0.20x $16.10 Million
SYSMEX CORP.UNSP.ADR 1/2 (0YX0) $388.36 Billion 11.79% 0.37x $4.70 Billion
INMODE LTD IS -01 (154) $683.20 Million 13.73% 0.12x $711.77 Million
HeraMED Limited (1I4) $2.59 Million -168.10% 0.60x $27.68 Million
Medtronic PLC (2M6) $1.75 Billion 30.35% 0.38x $83.04 Billion
Peijia Medical Limited (4WO) $3.02 Billion -19.02% 0.05x $305.26 Million
AVITA Medical Inc (51KB) $84.74 Million -31.47% 0.16x $172.49 Million
BRAINCOOL AB (5YL) $111.74 Million -54.84% 0.19x $18.88 Million
MICROPORT CARDIO.MEDTECH. (72X) $2.33 Billion -20.20% 0.10x $107.57 Million

About IMAGIN MEDICAL INC.

F:DPD3 Germany Medical Devices
Market Cap
$6.33K
€5.42K EUR
Market Cap Rank
#31902 Global
#2882 in Germany
Share Price
€0.00
Change (1 day)
+0.00%
52-Week Range
€0.00 - €0.00
All Time High
€1.23
About

Imagin Medical Inc., a urologic oncology company, focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It offers the i/Blue Imaging System, which detects bladder cancer with advanced proprietary optics and light sensors; and enCage Coil, a disposable and focal therapy precision ablation device for use in the treatment of prostate cancer. Th… Read more